Vestal Point Capital, LP Portfolio Holdings

Vestal Point Capital, LP

  • $1.69 Trillion
  • Q4 2024

Vestal Point Capital, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.69 Trillion distributed in 73 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jazz Pharmaceuticals PLC with a value of $120B, Cytokinetics Inc with a value of $111B, Merck & Co., Inc. with a value of $79.6B, Ascendis Pharma A/S with a value of $71.6B, and Ultragenyx Pharmaceutical Inc. with a value of $63.1B.

Examining the 13F form we can see an increase of $368B in the current position value, from $1.32T to 1.69T.

Vestal Point Capital, LP is based out at New York, NY

Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.69 Trillion
Healthcare: $212 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$8.65B
$120 Billion 7.12% of portfolio
975,000
Q4 2024 Added 8.33%
$4.18B
$111 Billion 6.55% of portfolio
2,350,000
Q4 2024 Added 56.67%
$240B
$79.6 Billion 4.72% of portfolio
800,000
Q4 2024 New
$8.54B
$71.6 Billion 4.24% of portfolio
520,000
Q4 2024 Added 108.0%
$2.76B
$63.1 Billion 3.74% of portfolio
1,500,000
Q4 2024 Added 100.0%
$10.4B
$62.1 Billion 3.68% of portfolio
900,000
Q4 2024 Reduced 43.75%
$12.9B
$56.5 Billion 3.35% of portfolio
860,000
Q4 2024 Added 115.0%
$664M
$53.4 Billion 3.17% of portfolio
3,025,000
Q4 2024 Reduced 36.32%
Soleno Therapeutics Inc
-
$47.6 Billion 2.82% of portfolio
-
Q4 2024 Added 47.22%
$3.31B
$47 Billion 2.78% of portfolio
600,000
Q4 2024 New
Structure Therapeutics Inc
-
$46.8 Billion 2.77% of portfolio
-
Q4 2024 Added 50.0%
$757M
$45.5 Billion 2.7% of portfolio
1,075,000
Q4 2024 New
$347M
$44.6 Billion 2.65% of portfolio
6,275,000
Q4 2024 Added 67.33%
$310M
$40.4 Billion 2.4% of portfolio
4,770,000
Q4 2024 Added 19.25%
$620M
$38.9 Billion 2.31% of portfolio
11,000,000
Q4 2024 Added 947.62%
$97.9M
$37.4 Billion 2.22% of portfolio
4,180,000
Q4 2024 Added 4.5%
$145B
$36.2 Billion 2.14% of portfolio
750,000
Q4 2024 Added 400.0%
Gsk PLC
-
$33.8 Billion 2.01% of portfolio
-
Q4 2024 Added 233.33%
$298M
$33.1 Billion 1.96% of portfolio
10,775,000
Q4 2024 Added 33.19%
$2.2B
$31.8 Billion 1.88% of portfolio
810,000
Q4 2024 Reduced 1.82%
$2.5B
$31.6 Billion 1.87% of portfolio
3,350,000
Q4 2024 New
$240B
$31.1 Billion 1.85% of portfolio
475,000
Q4 2024 New
$8.51B
$30.4 Billion 1.8% of portfolio
250,000
Q4 2024 New
$5.96B
$29.3 Billion 1.74% of portfolio
95,000
Q4 2024 Added 216.67%
$5.47B
$26.9 Billion 1.59% of portfolio
325,000
Q4 2024 New
Nyxoah Sa
-
$23.4 Billion 1.39% of portfolio
-
Q4 2024 New
Dianthus Therapeutics Inc
-
$23.4 Billion 1.39% of portfolio
-
Q4 2024 Added 172.15%
$3.74B
$23 Billion 1.36% of portfolio
495,000
Q4 2024 New
$929M
$20.7 Billion 1.23% of portfolio
1,760,000
Q4 2024 Added 17.33%
$4.68B
$20.8 Billion 1.23% of portfolio
595,000
Q4 2024 New
$597M
$18.2 Billion 1.08% of portfolio
1,440,000
Q4 2024 Reduced 42.4%
$252M
$17.4 Billion 1.03% of portfolio
1,630,000
Q4 2024 Added 307.5%
$6.23B
$15.5 Billion 0.92% of portfolio
475,000
Q4 2024 Added 280.0%
$7.51B
$14.8 Billion 0.88% of portfolio
1,250,000
Q4 2024 New
$71.5B
$14.2 Billion 0.84% of portfolio
20,000
Q4 2024 New
$899M
$13.8 Billion 0.82% of portfolio
300,000
Q4 2024 Added 650.0%
$483M
$13.8 Billion 0.82% of portfolio
990,000
Q4 2024 New
Bicara Therapeutics Inc
-
$12.4 Billion 0.73% of portfolio
-
Q4 2024 Added 67.06%
$61.8M
$12 Billion 0.71% of portfolio
5,600,000
Q4 2024 Added 11.37%
Solid Biosciences Inc
-
$11.4 Billion 0.68% of portfolio
-
Q4 2024 Added 1.79%
$35.9B
$10.1 Billion 0.6% of portfolio
75,000
Q4 2024 Reduced 25.0%
$24.5M
$9.85 Billion 0.58% of portfolio
11,500,000
Q4 2024 Added 904.37%
$3.67B
$9.64 Billion 0.57% of portfolio
375,000
Q4 2024 New
$641M
$9.14 Billion 0.54% of portfolio
485,000
Q4 2024 Added 14.12%
Lexeo Therapeutics Inc
-
$7.9 Billion 0.47% of portfolio
-
Q4 2024 Added 41.18%
$3.74B
$7.86 Billion 0.47% of portfolio
300,000
Q4 2024 New
$955M
$7.71 Billion 0.46% of portfolio
305,000
Q4 2024 New
$260M
$6.91 Billion 0.41% of portfolio
900,000
Q4 2024 Reduced 12.2%
$151M
$6.97 Billion 0.41% of portfolio
1,230,000
Q4 2024 Added 151.02%

Summary

  • Portfolio
  • No. of Stocks 73
  • Current Value $1.69 Trillion
  • Prior Value $1.32 Trillion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 25 stocks
  • Additional Purchases 32 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email